Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

2(25%)

Phase Distribution

Ph phase_3

38%

Ph phase_2

63%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

5(62.5%)

Phase 3Large-scale testing

3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Other(1)

Detailed Status

Completed5

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 3

Trials by Phase

Phase 25 (62.5%)

Phase 33 (37.5%)

Trials by Status

completed563%

unknown113%

terminated225%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_3

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

NCT00064623

completedphase_2

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

NCT00233155

completedphase_2

Clinical Trials (8)

Showing 8 of 8 trials

NCT00064623Phase 3

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

Completed

NCT00233155Phase 2

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

Completed

NCT00061776Phase 2

NGX-4010 for the Treatment of Postherpetic Neuralgia

Completed

NCT00068081Phase 3

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Completed

NCT00085761Phase 3

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Terminated

NCT00082316Phase 2

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

Completed

NCT00061152Phase 2

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

Unknown

NCT00089557Phase 2

An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

Terminated

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8